NDC 54473-184-01 - CounterAct Night

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
54473-184
Requested NDC
54473-184-01
Package NDCs from labels
54473-184-01, 54473-184-36
Manufacturer
Melaleuca, Inc.
Effective date
2019-12-09
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
CounterAct Night Content of LabelMelaleuca, Inc.2019-12-09HUMAN OTC DRUG LABEL

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
ACETAMINOPHENACTIVE INGREDIENT362O9ITL9DCOUNTERACT NIGHT (ACETAMINOPHEN, DIPHENYDRAMINE HCI, PHENYLEPHRINE HCI) TABLET, COATED [MELALEUCA, INC.]1
DIPHENHYDRAMINE HYDROCHLORIDEACTIVE INGREDIENTTC2D6JAD40COUNTERACT NIGHT (ACETAMINOPHEN, DIPHENYDRAMINE HCI, PHENYLEPHRINE HCI) TABLET, COATED [MELALEUCA, INC.]1
PHENYLEPHRINE HYDROCHLORIDEACTIVE INGREDIENT04JA59TNSJCOUNTERACT NIGHT (ACETAMINOPHEN, DIPHENYDRAMINE HCI, PHENYLEPHRINE HCI) TABLET, COATED [MELALEUCA, INC.]1
ACETAMINOPHENACTIVE MOIETY362O9ITL9DCOUNTERACT NIGHT (ACETAMINOPHEN, DIPHENYDRAMINE HCI, PHENYLEPHRINE HCI) TABLET, COATED [MELALEUCA, INC.]1
DIPHENHYDRAMINEACTIVE MOIETY8GTS82S83MCOUNTERACT NIGHT (ACETAMINOPHEN, DIPHENYDRAMINE HCI, PHENYLEPHRINE HCI) TABLET, COATED [MELALEUCA, INC.]1
PHENYLEPHRINEACTIVE MOIETY1WS297W6MVCOUNTERACT NIGHT (ACETAMINOPHEN, DIPHENYDRAMINE HCI, PHENYLEPHRINE HCI) TABLET, COATED [MELALEUCA, INC.]1
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61UCOUNTERACT NIGHT (ACETAMINOPHEN, DIPHENYDRAMINE HCI, PHENYLEPHRINE HCI) TABLET, COATED [MELALEUCA, INC.]1
CROSCARMELLOSE SODIUMINACTIVE INGREDIENTM28OL1HH48COUNTERACT NIGHT (ACETAMINOPHEN, DIPHENYDRAMINE HCI, PHENYLEPHRINE HCI) TABLET, COATED [MELALEUCA, INC.]1
CROSPOVIDONEINACTIVE INGREDIENT68401960MKCOUNTERACT NIGHT (ACETAMINOPHEN, DIPHENYDRAMINE HCI, PHENYLEPHRINE HCI) TABLET, COATED [MELALEUCA, INC.]1
FD&C BLUE NO. 1INACTIVE INGREDIENTH3R47K3TBDCOUNTERACT NIGHT (ACETAMINOPHEN, DIPHENYDRAMINE HCI, PHENYLEPHRINE HCI) TABLET, COATED [MELALEUCA, INC.]1
HYDROXYPROPYL CELLULOSEINACTIVE INGREDIENTRFW2ET671PCOUNTERACT NIGHT (ACETAMINOPHEN, DIPHENYDRAMINE HCI, PHENYLEPHRINE HCI) TABLET, COATED [MELALEUCA, INC.]1
HYPROMELLOSESINACTIVE INGREDIENT3NXW29V3WOCOUNTERACT NIGHT (ACETAMINOPHEN, DIPHENYDRAMINE HCI, PHENYLEPHRINE HCI) TABLET, COATED [MELALEUCA, INC.]1
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30COUNTERACT NIGHT (ACETAMINOPHEN, DIPHENYDRAMINE HCI, PHENYLEPHRINE HCI) TABLET, COATED [MELALEUCA, INC.]1
POLYETHYLENE GLYCOLINACTIVE INGREDIENT3WJQ0SDW1ACOUNTERACT NIGHT (ACETAMINOPHEN, DIPHENYDRAMINE HCI, PHENYLEPHRINE HCI) TABLET, COATED [MELALEUCA, INC.]1
POVIDONEINACTIVE INGREDIENTFZ989GH94ECOUNTERACT NIGHT (ACETAMINOPHEN, DIPHENYDRAMINE HCI, PHENYLEPHRINE HCI) TABLET, COATED [MELALEUCA, INC.]1
SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU4COUNTERACT NIGHT (ACETAMINOPHEN, DIPHENYDRAMINE HCI, PHENYLEPHRINE HCI) TABLET, COATED [MELALEUCA, INC.]1
STARCH, CORNINACTIVE INGREDIENTO8232NY3SJCOUNTERACT NIGHT (ACETAMINOPHEN, DIPHENYDRAMINE HCI, PHENYLEPHRINE HCI) TABLET, COATED [MELALEUCA, INC.]1
STEARIC ACIDINACTIVE INGREDIENT4ELV7Z65APCOUNTERACT NIGHT (ACETAMINOPHEN, DIPHENYDRAMINE HCI, PHENYLEPHRINE HCI) TABLET, COATED [MELALEUCA, INC.]1
TITANIUM DIOXIDEINACTIVE INGREDIENT15FIX9V2JPCOUNTERACT NIGHT (ACETAMINOPHEN, DIPHENYDRAMINE HCI, PHENYLEPHRINE HCI) TABLET, COATED [MELALEUCA, INC.]1

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 8 of 369 · 7,368 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
HERA SILKYSTAY FOUNDATION 28N1TITANIUM DIOXIDEAmorepacific Corporation5ec75100-153c-80cd-e063-6294a90a6d512026-10-26WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 28O1TITANIUM DIOXIDEAmorepacific Corporation5ec77f7a-4621-ac0c-e063-6294a90a3f702026-10-26WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 29N1TITANIUM DIOXIDEAmorepacific Corporation5ec7ab15-9cc1-d53a-e063-6294a90a41112026-10-26WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 29W1TITANIUM DIOXIDEAmorepacific Corporation5ec83b87-08bc-7590-e063-6294a90a0b782026-10-26WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 31C1TITANIUM DIOXIDEAmorepacific Corporation5ec857a3-7fd1-6461-e063-6394a90aacd72026-10-26WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 31N1TITANIUM DIOXIDEAmorepacific Corporation5ec871dc-f74e-765c-e063-6394a90a27a52026-10-26WarningsExact identifier
unii: 15FIX9V2JP
acetaminophen pain reliever fever reducerACETAMINOPHENPadagis Israel Pharmaceuticals Ltdb43974c3-4db9-4201-beee-b22596a2b2412026-10-26WarningsExact identifier
unii: 362O9ITL9D
NASAL and SINUS DECONGESTANTPHENYLEPHRINE HYDROCHLORIDEJHK Inc dba American Safety & First Aid63e51305-2575-49c4-9fda-7b3e1b4b6ede2026-10-26WarningsExact identifier
unii: 04JA59TNSJ
Acetaminophen PM Extra StrengthACETAMINOPHEN, DIPHENHYDRAMINE HCLFOODHOLD U.S.A., LLCfdd7ce80-d6be-41b9-affd-d024cf306b502026-10-26WarningsExact identifier
unii: TC2D6JAD40
unii: 362O9ITL9D
Headache Relief Extra StrengthACETAMINOPHEN, ASPIRIN, CAFFEINECVS Pharmacy9e459853-5951-4ae7-88a6-85b502e9dd412026-10-26WarningsExact identifier
unii: 362O9ITL9D
MUCINEX FAST-MAX NIGHTTIME COLD AND FLUACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, TRIPROLIDINE HYDROCHLORIDEReckitt Benckiser LLC3a24b06c-00a6-c2ef-e063-6294a90a4d722026-10-25WarningsExact identifier
unii: 362O9ITL9D
Mucinex Nightshift Cold and Flu Maximum StrengthACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND TRIPROLIDINE HYDROCHLORIDEReckitt Benckiser LLC316b5569-b66f-f30c-e063-6394a90ae1472026-10-25WarningsExact identifier
unii: 362O9ITL9D
HERA SILKYSTAY FOUNDATION 13N1TITANIUM DIOXIDEAmorepacific Corporation5eb19976-6983-3d9e-e063-6394a90a01ee2026-10-25WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 17C2TITANIUM DIOXIDEAmorepacific Corporation5eb338c7-e99c-887d-e063-6394a90a977c2026-10-25WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 17N1TITANIUM DIOXIDEAmorepacific Corporation5eb363fe-c2b2-9381-e063-6294a90ad0382026-10-25WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 17W1TITANIUM DIOXIDEAmorepacific Corporation5eb39387-7f6b-ce78-e063-6394a90a15ae2026-10-25WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 21C2TITANIUM DIOXIDEAmorepacific Corporation5eb3c3ad-8a77-0655-e063-6394a90ae9e02026-10-25WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 21N1TITANIUM DIOXIDEAmorepacific Corporation5eb3ddb5-4e2b-17d4-e063-6394a90aaa552026-10-25WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 22N1TITANIUM DIOXIDEAmorepacific Corporation5eb415b3-b1ba-42b8-e063-6394a90a90d72026-10-25WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 21W1TITANIUM DIOXIDEAmorepacific Corporation5eb42062-f298-5186-e063-6294a90ab0432026-10-25WarningsExact identifier
unii: 15FIX9V2JP

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.